Cargando…
Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening
Development of simple, convenient, and sensitive assay methods for pyrophosphatase (PPase) activity is of importance, for disease diagnosis and drug discovery. Herein, a simple, rapid, label-free, and sensitive fluorescence sensor for PPase activity assay is developed, using Cu(2+) doping-induced qu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359004/ https://www.ncbi.nlm.nih.gov/pubmed/30669286 http://dx.doi.org/10.3390/nano9010111 |
_version_ | 1783392123517665280 |
---|---|
author | Tian, Yishen Hao, Lijie Wang, Chao Yang, Xiaoyan Liu, Shufeng |
author_facet | Tian, Yishen Hao, Lijie Wang, Chao Yang, Xiaoyan Liu, Shufeng |
author_sort | Tian, Yishen |
collection | PubMed |
description | Development of simple, convenient, and sensitive assay methods for pyrophosphatase (PPase) activity is of importance, for disease diagnosis and drug discovery. Herein, a simple, rapid, label-free, and sensitive fluorescence sensor for PPase activity assay is developed, using Cu(2+) doping-induced quantum dot (QD) photoluminescence as a signal reporter. The Cu(2+) doping of ZnSe QD can induce a dopant-dependent emission response, which will be inhibited after the premixing of Cu(2+) with pyrophosphate (PPi), to form a Cu(2+)-PPi complex. Then, the hydrolysis of PPi into phosphate (Pi), specifically catalyzed by PPase, liberates the free Cu(2+) to regain the QD doping for the fluorescence response, which is highly dependent on the PPase activity. The PPase can be sensitively and selectively assayed, with a detection limit of 0.1 mU/mL. The developed sensing strategy can be also employed for the PPase inhibitor screening. Thus, the current QD doping-based sensing strategy offers an efficient and promising avenue for Cu(2+), PPi, or PPase-related target analysis, and might hold great potential for the further applications in the clinical disease diagnosis. |
format | Online Article Text |
id | pubmed-6359004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63590042019-02-06 Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening Tian, Yishen Hao, Lijie Wang, Chao Yang, Xiaoyan Liu, Shufeng Nanomaterials (Basel) Article Development of simple, convenient, and sensitive assay methods for pyrophosphatase (PPase) activity is of importance, for disease diagnosis and drug discovery. Herein, a simple, rapid, label-free, and sensitive fluorescence sensor for PPase activity assay is developed, using Cu(2+) doping-induced quantum dot (QD) photoluminescence as a signal reporter. The Cu(2+) doping of ZnSe QD can induce a dopant-dependent emission response, which will be inhibited after the premixing of Cu(2+) with pyrophosphate (PPi), to form a Cu(2+)-PPi complex. Then, the hydrolysis of PPi into phosphate (Pi), specifically catalyzed by PPase, liberates the free Cu(2+) to regain the QD doping for the fluorescence response, which is highly dependent on the PPase activity. The PPase can be sensitively and selectively assayed, with a detection limit of 0.1 mU/mL. The developed sensing strategy can be also employed for the PPase inhibitor screening. Thus, the current QD doping-based sensing strategy offers an efficient and promising avenue for Cu(2+), PPi, or PPase-related target analysis, and might hold great potential for the further applications in the clinical disease diagnosis. MDPI 2019-01-18 /pmc/articles/PMC6359004/ /pubmed/30669286 http://dx.doi.org/10.3390/nano9010111 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tian, Yishen Hao, Lijie Wang, Chao Yang, Xiaoyan Liu, Shufeng Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title | Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title_full | Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title_fullStr | Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title_full_unstemmed | Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title_short | Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening |
title_sort | quantum dot doping-induced photoluminescence for facile, label-free, and sensitive pyrophosphatase activity assay and inhibitor screening |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359004/ https://www.ncbi.nlm.nih.gov/pubmed/30669286 http://dx.doi.org/10.3390/nano9010111 |
work_keys_str_mv | AT tianyishen quantumdotdopinginducedphotoluminescenceforfacilelabelfreeandsensitivepyrophosphataseactivityassayandinhibitorscreening AT haolijie quantumdotdopinginducedphotoluminescenceforfacilelabelfreeandsensitivepyrophosphataseactivityassayandinhibitorscreening AT wangchao quantumdotdopinginducedphotoluminescenceforfacilelabelfreeandsensitivepyrophosphataseactivityassayandinhibitorscreening AT yangxiaoyan quantumdotdopinginducedphotoluminescenceforfacilelabelfreeandsensitivepyrophosphataseactivityassayandinhibitorscreening AT liushufeng quantumdotdopinginducedphotoluminescenceforfacilelabelfreeandsensitivepyrophosphataseactivityassayandinhibitorscreening |